Xconomy National

Archives

by in

Entry	Author	Date	Location
Xconomy Seattle’s Top 12 Life Sciences Stories of the Year	Luke Timmerman	12/28/11	Seattle
The Year in Seattle Medical Devices, Diagnostics, Health IT	Luke Timmerman	12/23/11	Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Some Notes on Immunex	Tom Alberg	11/29/11	Seattle
A Look Ahead for Washington State’s Life Sciences Cluster	Thong Le	11/16/11	Seattle
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News	Luke Timmerman	10/20/11	Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors	Luke Timmerman	10/18/11	Seattle
Immune Design Rakes In Another $11M From Prior VC Round	Luke Timmerman	10/05/11	Seattle
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
Presage Adds $1.5M	Luke Timmerman	08/10/11	Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus	Don Rule	08/08/11	Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News	Luke Timmerman	07/14/11	Seattle
Hutch, Sangamo Win $20M HIV Grant	Luke Timmerman	07/11/11	Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News	Luke Timmerman	06/09/11	Seattle
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch	Luke Timmerman	06/06/11	Seattle
Finding a Solution To Our Biotech Malaise Together	Richard Gayle	05/18/11	Seattle
Bill Gates’ Favorite Biofuel Company on the Docket for Thursday’s Alternative Fuels Event	Luke Timmerman	05/16/11	Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News	Luke Timmerman	05/12/11	Seattle
Matrix Genetics Pursues the Algae Fuel Dream in the Lab, Not With Big Steel Tanks, Giant Ponds	Luke Timmerman	05/12/11	Seattle
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up	Luke Timmerman	03/04/11	Seattle
Washington’s Innovation Corridor a Key to Recovery	Chris Rivera	02/18/11	Seattle
Top Trends to Watch in 2011 From Experts in Infotech, Biotech, Cleantech	Luke Timmerman	01/19/11	National
The Immunex Alumni, Hood Wins Russ Prize, Williams Grabs Biogen Gig, & More Seattle-Area Life Sciences News	Luke Timmerman	01/06/11	Seattle
Hutch Buys Building for $36M	Luke Timmerman	12/17/10	Seattle
Adaptive TCR Seeks to Dominate New Industry, Ultrasound on an iPhone, AVI Names CEO, & More Seattle-Area Life Sciences News	Luke Timmerman	12/16/10	Seattle
Adaptive TCR Seeks to Dominate New Industry in Profiling The Immune System	Luke Timmerman	12/13/10	Seattle
Hutch Snaps Up $5.6M at Holiday Gala	Luke Timmerman	12/08/10	Seattle
Sequenta Pockets $13M To Diagnose, Monitor Immune Systems Going Awry	Luke Timmerman	12/08/10	San Francisco
Ouch for Arch: VC Bob Nelsen Says Ikaria Will March On After Withdrawing Big IPO	Luke Timmerman	11/12/10	Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	11/11/10	Seattle
Page 1 of 5	next page »